Inspire Medical Systems Inc (INSP) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

Total Cash From Operating Activities Chart for Inspire Medical Systems Inc

Inspire Medical Systems Inc (INSP) operating cash flow for FY2025 was USD 117.0M, a -10.2% change from FY2024. Inspire Medical Systems Inc's operating cash flow moved from USD -22.3M in 2015 to USD 117.0M in 2025 over 10 years.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$2.06B
Implied Share Price
$71.11
Enterprise Value
$1.92B
Revenue (TTM)
$898.74M
EBITDA
$71.33M
Profit Margin
15.03%
Trailing P/E
15.66
Forward P/E
49.75
Price/Book (MRQ)
3.23
Price/Sales (TTM)
2.29
EV/EBITDA
27.63
EV/Revenue
2.23
Dividend Yield
—
Book Value
$28.56
Free Cash Flow (FY2025)
$78.48M
Free Cash Flow Yield
3.82%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.